Categories AlphaGraphs, Earnings, Health Care

Intuitive Surgical (ISRG) reports higher Q2 revenues and earnings

Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the second quarter of 2023, reporting higher revenues and adjusted profit.

Intuitive Surgical Q2 2023 earnings infographic

Second-quarter net profit, excluding one-off items, increased to $1.42 per share from $1.14 per share last year. Unadjusted net income was $420.8 million or $1.18 per share in Q2, compared to $307.8 million or $0.85 per share in the same period of the prior year.

The company reported net revenues of $1.76 billion for the second quarter, which is up 15% from the year-ago period. Instruments & Accessories revenues and Services revenues increased in double digits.

“We continue to focus on supporting our customers’ adoption, pursuing expanded indications, delivering excellence in quality and supply, and increasing productivity as we scale our business,” said Gary Guthart, Intuitive’s CEO.

Prior Performance

  • Intuitive Surgical Q4 2022 earnings infographic
  • Intuitive Surgical Q3 2022 earnings infographic

Most Popular

CCL Earnings: Highlights of Carnival Corporation’s Q4 2025 results

Cruise operator Carnival Corporation & plc (NYSE: CCL) on Friday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. Earnings topped analysts' expectations. Revenues

Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights

Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.

Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates

Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top